Literature DB >> 22223390

Synthesis of BMS-309403-related compounds, including [¹⁴C]BMS-309403, a radioligand for adipocyte fatty acid binding protein.

Toshihiko Okada1, Makoto Hiromura, Masato Otsuka, Shuichi Enomoto, Hiroyuki Miyachi.   

Abstract

Adipocyte fatty acid binding protein (A-FABP; FABP4), which is predominantly expressed in macrophages and adipose tissue, regulates fatty acid storage and lipolysis, and is also an important mediator of inflammation. Here, we report a synthesis of (14)C-labeled 2-[2'-(5-ethyl-3,4-diphenyl-1H-pyrazol-1-yl)biphenyl-3-yloxy]acetic acid (BMS309403), a potent and selective small-molecular FABP4 inhibitor, as a chemical tool for investigating the roles of FABP4 in inflammatory and metabolic disorders. The structure-activity relationship of several BMS derivatives for inhibition of FABP4 is also reported.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22223390     DOI: 10.1248/cpb.60.164

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  2 in total

1.  Inhibition of Fatty Acid Binding Protein 4 in Obese Male Mice Adversely Affects Reproductive Parameters.

Authors:  Tevfik Balci; Rahim Kocabas; Gokhan Cuce; Mehmet Akoz
Journal:  J Reprod Infertil       Date:  2021 Jan-Mar

2.  Development of a radioiodinated triazolopyrimidine probe for nuclear medical imaging of fatty acid binding protein 4.

Authors:  Kantaro Nishigori; Takashi Temma; Satoru Onoe; Sotaro Sampei; Ikuo Kimura; Masahiro Ono; Hideo Saji
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.